Final set of results from Mediclinic as a listed company?

  • 📰 Moneyweb
  • ⏱ Reading Time:
  • 9 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 77%

Portugal Notícia Notícia

Portugal Últimas Notícias,Portugal Manchetes

The deal with the Remgro-led consortium will be finalised in Q1 2023 and will see Mediclinic delist from the JSE, the LSE and the Namibian Stock Exchange.

Interim results from Mediclinic show that minority shareholders are probably getting a fair deal from the Remgro-led consortium that made an offer of £5.04 per share for their shares. Based on the latest results, the offer equates to a price-earnings ratio of 22 times, while shareholders are bound to appreciate the advantages of having a bird in the hand rather than seeing them flying around the bush.

The scheme of arrangement has received approval from all the relevant authorities in different countries, except in SA – the only uncertainty remaining for shareholders.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

 /  🏆 5. in PT
 

Obrigado pelo seu comentário. Seu comentário será publicado após ser revisado.

Portugal Últimas Notícias, Portugal Manchetes